Mitku Mammo Taderegew

Mitku Mammo Taderegew

Auto-generated profile, based on publicly available information

Mitku Mammo Taderegew

Department of Biomedical Sciences, Asrat Woldeyes Health Science Campus, Debre Berhan University, Ethiopia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
TGTewodros Gebremariam
Tewodros Gebremariam
ATAmare Abera Tareke
Amare Abera Tareke
GWGashaw Garedew Woldeamanuel
Gashaw Garedew Woldeamanuel
Purpose: Anemia is one of the common complications of diabetes mellitus (DM), which has an adverse effect on the progression and development of other diabetes-related complications. In spite of this, relatively little information is available on the prevalence of anemia and associated factors among type 2 diabetes mellitus (T2DM) patients in Ethiopia, particularly in the study area. Thus, this study assessed the prevalence of anemia and associated factors among T2DM patients at Debre Berhan Referral Hospital (DBRH), North-East, Ethiopia. Patients and Methods: A hospital-based cross-sectional study was conducted from April 1 to May 30, 2019, among 249 T2DM patients with follow up at DBRH, selected using a systematic random sampling technique. Data were collected by face-to-face interviews, anthropometric measurements, and laboratory tests; such as hemoglobin measurements, red blood indices, and serum creatinine analysis. The data were coded and entered into Epi-data manager version 4.4.1.0, and analysis by using SPSS version 22 was carried out. To identify the determinant factors of anemia, bivariate and multivariate logistic regression analyses were performed. P-value < 0.05 was considered as statistically significant. Results: The study showed 20.1% of the participants were anemic. Being age > 60 years (AOR=3.06, 95% CI: 1.32– 7.11), poor glycemic control (AOR=2.95, 95% CI: 1.22– 7.15), eGFR 60– 89.9 mL/min/1.73m2 (AOR=2.91, 95% CI: 1.15– 7.37), eGFR < 60 mL/min/1.73m2 (AOR=6.58, 95% CI: 2.42– 17.93), DM duration > 10 years (AOR= AOR=2.75, 95% CI: 1.17– 6.48), and having diabetic complications (AOR=3.81, 95% CI: 1.65– 8.81) were significantly associated with anemia. Conclusion: One out of five T2DM patients had anemia. Poor glycemic control, decreased eGFR, presence of DM complications, duration of DM > 10 years, and age > 60 years were significantly associated with the occurrence of anemia among T2DM. Regular screening for anemia in all T2DM patients may help in the early detection and management of anemia.

5 October 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
GWGashaw Garedew Woldeamanuel
Gashaw Garedew Woldeamanuel
AWAlemayehu Wondie
Alemayehu Wondie
AGAtsede Getawey
Atsede Getawey
AAAbera Nesiru Abegaz
Abera Nesiru Abegaz
FAFentahun Adane
Fentahun Adane
Objective: The study intended to assess the pooled prevalence of vitamin D deficiency (VDD) and its associated factors among patients with type 2 diabetes mellitus (T2DM).Design: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were employed to plan and conduct this systematic review and meta-analysis.Data sources: PubMed, Medline, Google Scholar, Web of Science, Science Direct and the Worldwide Science database were searched from their inception to 31 January 2023.Methods: Data were extracted using a standardised data extraction format prepared in Microsoft Excel. The inverse variance (I2) test was used to evaluate the presence of heterogeneity across the included studies. To identify the possible source of heterogeneity, subgroup analysis was carried out. Funnel plot symmetry, Begg’s and Egger’s tests were used to evaluate the existence of publication bias. In addition, factors associated with VDD among patients with T2DM were examined. All statistical analyses were carried out with STATA V.14 software.Results: A total of 54 studies with 38 016 study participants were included in the study. The pooled prevalence of VDD among patients with T2DM was found to be 64.2% (95% CI 60.6% to 67.8%) with a substantial level of heterogeneity (I2=98.2%; p<0.001). Results of the subgroup analysis indicated that the pooled prevalence of VDD among patients with T2DM was highest (70.9%) in African nations and lowest (57.1%) in Middle East countries. Being female (pooled OR (POR) 1.60, 95% CI 1.29 to 1.97), having poor glycaemic control (POR 2.50; 95% CI 1.74 to 3.59), hypertension (POR 1.21; 95% CI 1.08 to 1.36), obesity (body mass index ≥25) (POR 1.68; 95% CI 1.16 to 2.44), dyslipidaemia (POR 2.54, 95% CI 1.37 to 4.73), albuminuria (POR 2.22, 95% CI 1.71 to 2.95), nephropathy (POR 1.58; 95% CI 1.08 to 2.31) and retinopathy (POR 1.48: 95% CI 1.17 to 1.89) were predictors of VDD among patients with T2DM.Conclusions: More than half of patients with T2DM were suffering from VDD. Being female, having poor glycaemic control, hypertension, obesity, dyslipidaemia, albuminuria, nephropathy and retinopathy were the predictors of VDD among patients with T2DM.

9 March 2021 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ATAlemnesh Abebe Taye
Alemnesh Abebe Taye
WAWondwosen Asegidew
Wondwosen Asegidew
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
YBYonas Girma Bizuwork
Yonas Girma Bizuwork
BZBetregiorgis Zegeye
Betregiorgis Zegeye
Background: Lack of exclusive breastfeeding during the first half-year of life is an important risk factor for childhood morbidity and mortality. Despite this, less than 40% of infants below 6 months are exclusively breastfed worldwide. This is because breastfeeding is declining and being replaced by formula feeding. Nowaday, formula feeding has become a more common practice in urban communities of developing countries. However, relatively little information is available regarding formula feeding practice and its associated factors in Ethiopia, particularly in Addis Ababa. Hence, this study was aimed at assessing the prevalence of formula feeding practice and its associated factors among mothers of an infant aged 0–6 months in Addis Ababa, Ethiopia. Methods: A community-based cross-sectional study was conducted from April-1 to May 30/2020 among 494 mothers with infants 0–6 months of age. Data were collected using a pre-tested structured questionnaire. Data were entered and cleaned by using Epi data version 3.1 and analysed by SPSS software version 25. Then data were processed by using descriptive analysis, including frequency distribution, and summary measures. The degree of association was assessed using binary logistic regression analysis. P-value < 0.05 was considered statistically significant. Result: The prevalence of formula feeding and pre-lacteal feeding practice was 46.2 and 34.4%, respectively. Educational status with a diploma and above (AOR = 3.09, 95%CI: 1.56–6.14), delivery by cesarean section (AOR = 6.13, 95%CI: 4.01–9.37), pre-lacteal feeding practice (AOR = 7.61, 95%CI: 4.11–11.06), and delayed initiation of breastfeeding (after 1 h to 1 day (AOR = 3.43, 95% CI: 1.59–7.40), after 1 day to 3 days (AOR = 3.71, 95% CI: 1.51–9.41), and after 3 days (AOR = 5.41, 95% CI: 2.15–13.60)) were significantly associated with formula feeding practice. Conclusions: Nearly half of the participants were practiced formula-feeding for their infant. Educational status of mothers, the timing of initiation of breastfeeding, delivery by cesarean section, and pre-lacteal feeding practice were significantly associated with formula feeding practice. Therefore, early initiation of breastfeeding, educating mothers about the risks associated with pre-lacteal feeding, and supporting mothers who gave birth by cesarean section for exclusive breastfeeding should be encouraged at the community and institutional levels.

1 February 2021 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
GWGashaw Garedew Woldeamanuel
Gashaw Garedew Woldeamanuel
MEMamo Solomon Emeria
Mamo Solomon Emeria
MTMelkamu Tilahun
Melkamu Tilahun
GYGetachew Yideg Yitbarek
Getachew Yideg Yitbarek
BZBetregiorgis Zegeye
Betregiorgis Zegeye
Purpose: Platelet indices have been shown to be associated with complications of diabetes mellitus (DM). However, the clinical relevance of platelet indices for assessing the risk of being microvascular complications among patients with DM is largely overlooked. Hence this study aimed to determine the association of platelet indices with microvascular complications among type 2 DM patients. Patients and Methods: A hospital-based cross-sectional study was conducted among 352 type 2 DM patients from April 1 to May 30/2019 at Debre Berhan Referral Hospital. Data were collected by interview, physical measurements, document review, and laboratory tests. Then the data were entered into Epi-data manager-4.4.1.0 and exported into SPSS-25 for analysis. Platelet indices were compared between participants with and without microvascular complications using an independent t-test. A logistic regression model was used to assess the association between microvascular complications and platelet indices. All inferences were considered statistically significant at P< 0.05. Results: One hundred seventeen (33.2%) of participants were suffering from at least one microvascular complications. The mean platelet volume (MPV), platelet distribution width (PDW), and platelet-large cell ratio (P-LCR) were significantly increased in DM patients with complications as compared to without complications (13.57± 2.17fl vs. 11.76± 1.93fl), (16.57± 2.49fl vs. 14.97± 2.41fl) and (28.09± 7.58% vs. 24.19± 6.46%), respectively (all are P˂0.001). In multivariate logistic regression analysis, MPV (AOR=1.68, 95% CI: 1.37– 2.05), PDW (AOR=1.37, 95% CI: 1.15– 1.63), P-LCR (AOR=1.07, 95% CI: 1.01– 1.14), age (AOR=1.07, 95% CI: 1.01– 1.12), and duration of DM (AOR=1.31, 95% CI: 1.18– 1.46) were significantly associated with the presence of microvascular complications. Conclusion: MPV, PDW, and P-LCR were significantly higher among type 2 DM patients with microvascular complications. This indicates that platelet indices can be used as prognostic markers of vascular complications and can be used as simple and cost-effective parameters to predict microvascular complications particularly in patients with old age and long duration of DM.

2 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
AWAlemayehu Wondie
Alemayehu Wondie
TTTamene Fetene Terefe
Tamene Fetene Terefe
TTTadesse Tsehay Tarekegn
Tadesse Tsehay Tarekegn
FGFisha Alebel GebreEyesus
Fisha Alebel GebreEyesus
BZBetregiorgis Zegeye
Betregiorgis Zegeye
Introduction: Anemia is a serious complication of chronic kidney disease (CKD) with a significant adverse outcome on the burden and progression of the disease. Hence, the study intended to assess the pooled prevalence of anemia and its predictors among CKD patients in Sub-Saharan African nations. Methods: To identify the relevant studies systematic searches were carried out in Medline, EMBASE, HINARI, Google Scholar, Science Direct, and Cochrane Library. From selected studies, data were taken out with a standardized data extraction format prepared in Microsoft Excel. Inverse variance (I2) tests were employed to evaluate the heterogeneity across the included studies. Due to substantial heterogeneity among the studies, a random-effects meta-analysis technique was employed to estimate the pooled prevalence of anemia. Subgroup analysis, sensitivity analysis, and meta-regression analysis were carried out to search the possible bases of heterogeneity. Funnel plot symmetry, Begg’s test, and Egger’s regression test were employed to assess the existence of publication bias. In addition, factors associated with anemia among CKD patients were examined. All statistical analyses were carried out with STATA™ Version 14 software. Results: A total of 25 studies with 5042 study participants were considered in this study. The pooled prevalence of anemia among CKD patients was estimated to be 59.15% (95% CI, 50.02–68.27) with a substantial level of heterogeneity as evidenced by I2 statistics (I2 = 98.1%; p < 0.001). Stage of CKD (3–5) (pooled odds ratio (POR) = 5.33, 95% CI:4.20–6.76), presence of diabetes mellitus (POR = 1.75, 95% CI: 1.10–2.78), hemodialysis history (POR = 3.06, 95% CI: 1.63–5.73), and female sex (POR = 2.50, 95% CI: 1.76–3.55) were significantly related with anemia. Conclusions: More than half of CKD patients were suffering from anemia. Stage of CKD, presence of DM, hemodialysis history, and being female sex were factors associated with anemia among CKD patients.

5 November 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
MTMitku Mammo Taderegew
Mitku Mammo Taderegew
Background: Chronic kidney disease (CKD) is the known cause of morbidity and mortality among diabetes mellitus (DM) patients. Targeted screening of renal impairment based on estimated glomerular filtration rate (eGFR) among DM patients has potential benefits in early identification and treatment of CKD. Hence, this study was aimed to estimate the magnitude of renal impairment using eGFR among type 2 DM patients.Methods: An institution-based cross-sectional study was conducted from February-1 to April 30/2020 among 422 type 2 DM patients in Northeast Ethiopia. Data were collected by the semi-structured questioner and serum creatinine measurement. The collected data were edited into Epi-data manager version 4.4.1.0, and the analysis was performed by SPSS-25. The Simplified Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology (CKD-EPI), and Cockcroft-Gault (C-G) equations were used to calculate eGFR.Results: Of all study participants, 82(19.4%), 92(21.8%), and 103(24.4%) had eGFR < 60 ml/min/1.73 m2, according to the MDRD, CKD-EPI, and C-G equations, respectively. Female sex, (MDRD:AOR = 4.44, 95%CI:1.97–9.97, CKD-EPI:AOR = 3.17, 95%CI:1.27–6.17, and C-G:AOR = 2.65, 95%CI:1.35–5.21), duration ≥ 10 years (MDRD:AOR = 3.38, 95%CI:1.45–7.92, CKD-EPI:AOR = 3.09, 95%CI:1.07–7.77, and C-G:AOR = 2.92, 95%CI:1.29–6.61), age ˃60 years (MDRD:AOR = 2.29, 95%CI:1.09–4.77, CKD-EPI:AOR = 4.12, 95%CI:1.68–6.78, and C-G: AOR = 3.42, 95%CI:1.77–6.60), hypertension (MDRD:AOR = 3.12, 95%CI:1.51–6.45, CKD-EPI: AOR = 4.21,95%CI:2.07–7.98, and C-G:AOR = 3.99, 95%CI:2.08–7.65), poor glycemic control (MDRD:AOR = 2.82, 95%CI:1.13–7.05, and C-G:AOR = 2.34, 95%CI:1.09–5.04), and body mass index (MDRD:AOR = 1.11, 95%CI:1.01–1.22, and CKD-EPI:AOR = 2.43, 95%CI:1.27–5.76) were significantly associated with renal impairment.Conclusion: Renal impairment was prevalent among type 2 DM patients. Older age, female sex, duration, hypertension, poor glycemic control, and BMI were significantly associated with renal impairment.